skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I have been watching CZO CLR GUD NLN PLI and GPS for some time and I am considering buying into some of these Companies at these current low prices. I have 2 questions. a) Are the fundamentals sound?? and b) How would you rank them for mid term growth. Thanks for your considered opinion
Read Answer Asked by Bob on December 08, 2017
Q: Peter,
In what order would you add to the above smaller positions today ?
Any you would outright sell today ?
Thank you, Paul
Read Answer Asked by Paul on November 23, 2017
Q: I am getting tired of waiting on these to show some positive moves. Please give me your opinion if I should hold on or move on. Thanks in advance.
Read Answer Asked by Richard on November 21, 2017
Q: Amongst other names I hold the above noted names and am wondering if you think I should exit any of the names listed or hold on as all have done relatively poorly? Thanks, Ian
Read Answer Asked by Ian on November 21, 2017
Q: These four losing stocks of low weighing in my portfolio. Please advise if they are worth holding for recovery. CXI, SYZ and KBL are thinly traded. Thank you.
Bill
Read Answer Asked by Bill on November 20, 2017
Q: Good Morning Peter and Team, great job on the site ! The above are our laggers (vs a much longer list of out performers; thank you !). I'm assuming that unless they have strong news they will struggle into next year with tax loss selling. In what order would you part with them if you wanted to move on ? Which one or 2 do you think have the best potential that you would even add to them ? Thank you.
Read Answer Asked by Paul on November 03, 2017
Q: I'm looking for growth stocks from the Growth Portfolio that have been beaten up and are potentially poised to rebound soon and have the highest possible up side for my TFSA.

I your view currently , with the exception of ITC which I just purchased. Which other one or two would you consider right now.

Thanks
Read Answer Asked by Henry on October 16, 2017
Q: A two part question so do dock me two credits:

1. GUD: just about of patience with this stock which is down 18% this year. I know Goodman's reputation, and they have plenty of cash, and it took Paladin a long time to pay off, but sales are minimal, and more significantly, there doesn't appear to be much going on. Can you give me a plausible reason to hang in?

2. Other than the REITS - csh, exe, nwh - and your fave SIS, is there anything worth considering in this sector in Canada, or should I turn to the U.S.? Tecsys is technically in the Tech sector but could you reasonably consider it a healthcare stock?

Thanks!
Read Answer Asked by Kim on October 16, 2017
Q: Hi,
Just curious. Prometic float display a number of shares of 683 781 000 which means that any 1 dollar tick will increase the value of the company by $ 683 781 000.
I show assets of 62M and liabilities of 121M
I show revenues of 4M.
I know that you will answer discounted cash flow and phase 3 trials. but in this new world of ...." I don't care about valuations type of thinking" would it make sense to really ask how high the stock value will go.
CDJ
Read Answer Asked by claude on October 04, 2017
Q: Hello Peter,
My Frescii shares have tumbled 50% and am not sure if it is worth holding. What is your opinion? Do i hold or replace it with prometic or crh medical or for longer term knight (gud). With respect to Jean Coutu, would you expect the stock to go above 24.50 at a later point (higher offer) as my average cost is about that range or simply let the merger go through and I will get cash and some metro stock. Thank you.
Read Answer Asked by umedali on September 29, 2017
Q: Hi there, just looking for further clarification on PLI, have you assessed the risks in Prometic not receiving approval for the Plasminogen BLA from the FDA? Could it be possible that PLI raised further funds very quickly, at a substantial discount, at $1.70, trading well over $2 at that time, suspecting they will not be approved?
"The Corporation is responding diligently to all FDA requests in relation to the BLA review. The Corporation will provide further updates on the expected timeline of regulatory approval as soon as available"
Could it be possible that PLI is suspecting the FDA is looking for further clinical data for approval, which could take an additional 12 to 18 months for final approval? Have you assessed these types of risks in your modelling for the Growth Portfolio holding? Where do you see the stock price trading at, if the above scenario does occur?
Hope I am wrong above!
Thanks!
Read Answer Asked by Hussein on August 17, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!